We share our Insights on a regular basis.

Media Contacts

Terra Liddell: Chief Marketing Officer; Washington, DC; Email

Angela Robinson: Director of Branding and Communications; Washington, DC; Email

IP Updates

Unified Patent Court (UPC) Hub

2026

Articles

When the Classroom Goes Dark: Lessons from the Canvas Breach for Corporate Cyber Preparedness

July 8, 2026

Articles

Enforcing Your Patent Rights at Sea: A UK Perspective

June 18, 2026

Articles

EPR Academy, Part 4 of 6: Choosing Between EPR, IPR, PGR, and Reissue

July 1, 2026

Articles

Highlights and Implications of the UK Corporate Plan for the UKIPO

July 17, 2026

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

IP Updates

Too Concrete to Fail: Ceiva’s Guidance on the Use of Sufficiently Concrete Structures to Overcome Section 101 Rejections

July 28, 2026

At the PTAB Blog

Deadline Evolution: Director Extends Deadline for Requesting Director Review of Institution Grants to 30 Days

June 30, 2026

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Recent Insights

to

Downloadable Media

Event Type

Hosting Organization

Finnegan-Hosted

Articles

This Article Was Written Entirely by AI — Welcome to Synthetic Patent Litigation

This Article Was Written Entirely by AI — Welcome to Synthetic Patent Litigation This Article Was Written Entirely by AI — Welcome to Synthetic Patent Litigation

July/August 2026

IP Litigator

Articles

Choice of Law in Patent Appeals: The Federal Circuit’s Issue-by-Issue Framework

Choice of Law in Patent Appeals: The Federal Circuit’s Issue-by-Issue Framework Choice of Law in Patent Appeals: The Federal Circuit’s Issue-by-Issue Framework

May/June 2026

IP Litigator

Articles

Section 337 After Lashify: Practical Implications for Non-U.S. Companies: What the Federal Circuit’s March 2025 Decision Means for Those Who Can Credibly Bring an ITC Case

Section 337 After Lashify: Practical Implications for Non-U.S. Companies: What the Federal Circuit’s March 2025 Decision Means for Those Who Can Credibly Bring an ITC Case Section 337 After Lashify: Practical Implications for Non-U.S. Companies: What the Federal Circuit’s March 2025 Decision Means for Those Who Can Credibly Bring an ITC Case

November/December 2025

IP Litigator

Articles

Structuring Patent Royalties to Avoid Unnecessary U.S. Customs Duties: Lessons from CBP Rulings

Structuring Patent Royalties to Avoid Unnecessary U.S. Customs Duties: Lessons from CBP Rulings Structuring Patent Royalties to Avoid Unnecessary U.S. Customs Duties: Lessons from CBP Rulings

May/June 2025

IP Litigator

Articles

Recovering for Foreign Sales on a U.S. Patent: The Global Implications of the Federal Circuit’s Recent Decision in Brumfield

Recovering for Foreign Sales on a U.S. Patent: The Global Implications of the Federal Circuit’s Recent Decision in Brumfield Recovering for Foreign Sales on a U.S. Patent: The Global Implications of the Federal Circuit’s Recent Decision in Brumfield

September/October 2024

IP Litigator

Articles

Using Statements from Foreign Patent Office Proceedings to Construe U.S. Patent Claims

Using Statements from Foreign Patent Office Proceedings to Construe U.S. Patent Claims Using Statements from Foreign Patent Office Proceedings to Construe U.S. Patent Claims

September/October 2023

IP Litigator

Articles

Finding Favorable Fora for Foreign Firms

Finding Favorable Fora for Foreign Firms Finding Favorable Fora for Foreign Firms

May 9, 2023

IP Litigator

IP Updates

Finnegan to Argue Before the Supreme Court on Behalf of Navy Veteran Finnegan to Argue Before the Supreme Court on Behalf of Navy Veteran

October 3, 2022

Articles

Out of the ITC in 100 Days

Out of the ITC in 100 Days Out of the ITC in 100 Days

May/June 2022

IP Litigator

Articles

As the Curtain Falls on CBM Review, What’s Next for Financial Institutions?

As the Curtain Falls on CBM Review, What’s Next for Financial Institutions? As the Curtain Falls on CBM Review, What’s Next for Financial Institutions?

March/April 2022

IP Litigator

Articles

A Retrospective on Myriad Genetics: What Makes Medical Diagnostics Patent-Eligible 8 Years Later?

A Retrospective on Myriad Genetics: What Makes Medical Diagnostics Patent-Eligible 8 Years Later? A Retrospective on Myriad Genetics: What Makes Medical Diagnostics Patent-Eligible 8 Years Later?

May/June 2021

IP Litigator

Articles

Appealing Institution Issues and Section 314(d) Appealing Institution Issues and Section 314(d)

July/August 2020

IP Litigator